These cancers depend on rogue cells multiplying uncontrollably caused by DNA abnormalities (mutations) in important pathways involved in the generation of cancer and cancer stem cells. When there are mutations in these pathways, cancer cells and cancer stem cells, run rogue, multiply and spread uncontrollably.
Take a biopsy (current procedure).
Analyse tumour tissue for critical mutations. This is a simple test using established technology.
Select patients whose tumours have critical mutations.
Treat selected patients with the matching pathway inhibitor. Anastasis has several pathways inhibitors ready for development.
This treatment, by targeting specific and critical mutations, could potentially provide a breakthrough in the treatment of cancer types with significant clinical unmet need.
Daily Mail, UK - Tue, Aug 28, 2018
Daily Express, UK - Sun, Apr 22, 2018